Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of AI as a Third Reader and During Consensus in a Double Reading Breast Cancer Screening Program in Sweden

NCT05048095 is registered in ClinicalTrials.gov with Ostergotland County Council, Sweden as lead sponsor.

NCT NCT05048095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05048095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of AI as a Third Reader and During Consensus in a Double Reading Breast Cancer Screening Program in Sweden
Lead sponsor
Ostergotland County Council, Sweden
Phase
Observational
Overall status
Completed
Start date
October 15, 2021
Completion date
February 15, 2022
Enrollment
15,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer